Drug · DIN 02413523
MYLAN-RISPERIDONE ODT
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since November 15, 2021; first marketed October 24, 2013.
- Drug Identification Number (DIN)
- 02413523
- Company (DIN owner)
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Orally-Disintegrating)
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- June 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 4 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 3, 2013: NOC 14778Abbreviated New Drug Submission (ANDS)
Other DINs named MYLAN-RISPERIDONE ODT
- DIN 02413485 · Cancelled Post Market
- DIN 02413493 · Cancelled Post Market
- DIN 02413507 · Cancelled Post Market
- DIN 02413515 · Cancelled Post Market